France Grants Reimbursed Compassionate Access for BOT/BAL in Refractory MSS Colorectal Cancer - OncoDaily France grants reimbursed compassionate access to Agenus’ BOT/BAL for refractory MSS metastatic CRC, offering new hope for patients.

France Grants Reimbursed Compassionate Access for BOT/BAL in Refractory MSS Colorectal Cancer

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #BOT/BAL #MSSCRC #ColorectalCancer #Agenus